tenilsetam has been researched along with Cognition Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Münch, G; Palm, D; Riederer, P; Schindler, U; Schinzel, R; Schraven, E; Taneli, Y | 1 |
1 other study(ies) available for tenilsetam and Cognition Disorders
| Article | Year |
|---|---|
The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation.
Topics: Aging; Alzheimer Disease; Cognition Disorders; Glycation End Products, Advanced; Glycosylation; Humans; Macromolecular Substances; Nerve Tissue Proteins; Piperazines; Psychotropic Drugs; Thiophenes | 1994 |